(Q34618061)

3 August 2017

title

Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. (English)

1 reference

3 August 2017

Mansooreh Jaberipour

1

1 reference

3 August 2017

Mojtaba Habibagahi

2

1 reference

3 August 2017

Ahmad Hosseini

3

1 reference

3 August 2017

Saadat Rezai Habibabad

4

1 reference

3 August 2017

Abdolrasoul Talei

5

1 reference

3 August 2017

Abbas Ghaderi

6

1 reference

3 August 2017

publication date

21 March 2010

1 reference

Pathology Oncology Research

3 August 2017

published in

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

547-551

1 reference

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

3 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12253-010-9256-8

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

21 January 2018

1 reference

12 December 2020

Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.

1 reference

12 December 2020

Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis

1 reference

12 December 2020

Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells

1 reference

12 December 2020

FOXP3 expression and overall survival in breast cancer.

1 reference

12 December 2020

Regulatory T cells and tumour immunity - observations in mice and men.

1 reference

12 December 2020

Assessing the in vitro suppressive capacity of regulatory T cells

1 reference

12 December 2020

Evidence for immune defects in breast and lung cancer patients

1 reference

12 December 2020

[Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].

1 reference

12 December 2020

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

12 December 2020

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.

1 reference

12 December 2020

Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

1 reference

12 December 2020

The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

12 December 2020

Regulatory T cells and mechanisms of immune system control

1 reference

12 December 2020

Control of T-cell activation by CD4+ CD25+ suppressor T cells

1 reference

12 December 2020

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

12 December 2020

Regulatory T cells: key controllers of immunologic self-tolerance

1 reference

12 December 2020

Tumor-induced immune dysfunction: the macrophage connection.

1 reference

12 December 2020

Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma.

1 reference

12 December 2020

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

1 reference

12 December 2020

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

12 December 2020

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

12 December 2020

Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

1 reference

12 December 2020

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

12 December 2020

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

12 December 2020

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

12 December 2020

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

1 reference

12 December 2020

Increase of regulatory T cells in the peripheral blood of cancer patients.

1 reference

12 December 2020

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

1 reference

12 December 2020

Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies

1 reference

12 December 2020

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

12 December 2020

10.1007/S12253-010-9256-8

Identifiers

DOI

1 reference

3 August 2017

1 reference